Stock data
Edwards Lifesciences Corporation (EW)
Edwards Lifesciences Corporation (EW) reported revenue of US$6.07B and net income of US$1.07B for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$6.07B | US$4.73B | US$1.26B | US$1.07B | — |
| 2024 | US$5.44B | US$4.32B | US$1.38B | US$4.17B | — |
| 2023 | US$5.01B | US$4.03B | US$1.31B | US$1.40B | — |
| 2022 | US$4.46B | US$3.74B | US$1.50B | US$1.52B | — |
| 2021 | US$5.23B | US$3.98B | US$1.69B | US$1.50B | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$1.74B | US$241.90M | — |
| 2026-03-31 | US$1.65B | US$380.70M | — |
| 2025-12-31 | US$1.57B | US$91.20M | — |
| 2025-09-30 | US$1.55B | US$291.10M | — |
| 2025-06-30 | US$1.53B | US$333.20M | — |
| 2025-03-31 | US$1.41B | US$358.00M | — |
| 2024-12-31 | US$1.39B | US$385.60M | — |
| 2024-09-30 | US$1.35B | US$3.07B | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.